News Rumour mill says AstraZeneca may be eyeing a takeover of Mer... AstraZeneca is rumoured to be considering a bid to take control of its longstanding partner Mereo BioPharma, according to a
News UK biotech Mereo gears up for key brittle bone drug data UK biotech Mereo BioPharma is hoping the coming months will transform its fortunes as it prepares for potentially pivotal data for a brittle bone disease drug.
News ESC: MSD/Bayer's Verquvo disappoints in heart failure trial Bayer and MSD's hopes of expanding the use of Verquvo in heart failure have been dashed by a failed phase 3 trial.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
